Efficacy of abatacept, a selective co-stimulation modulator, in oxazolone-induced colitis

被引：0
|
作者：
Yang, Xiaoxia
Stetsko, Dawn
Xie, Jenny
Nadler, Steve
Suchard, Suzanne
Salter-Cid, Luisa
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A227 / A227
页数：1
相关论文
共 50 条
  • [21] The selective co-stimulation modulator abatacept decreases synovial inflammation and expression of pro-inflammatory cytokines in patients with rheumatoid arthritis.
    Buch, M
    Boyle, D
    Saleem, B
    Rosengren, S
    English, A
    Raymond, R
    Vratsanos, G
    Weiss, R
    Firestein, GS
    Emery, P
    Reece, R
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S446 - S446
  • [22] Activation of Bone Marrow Adaptive Immunity in Type 2 Diabetes: Rescue by Co-stimulation Modulator Abatacept
    Santopaolo, Marianna
    Sullivan, Niall
    Thomas, Anita Coral
    Alvino, Valeria Vincenza
    Nicholson, Lindsay B.
    Gu, Yue
    Spinetti, Gaia
    Kallikourdis, Marinos
    Blom, Ashley
    Madeddu, Paolo
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [23] Efficacy and safety of the selective co-stimulation modulator abatacept with methotrexate for treating rheumatoid arthritis: 1-year clinical and radiographic results from the Phase III AIM (Abatacept in Inadequate responders to Methotrexate) trial
    Hall, S.
    Hanrahan, P.
    Cheng, T. T.
    Lin, H. Y.
    Westhovens, R.
    Moreland, L.
    Emery, P.
    Russell, A.
    Kremer, J.
    INFLAMMATION RESEARCH, 2005, 54 : S110 - S110
  • [24] Tetramethylpyrazine improves oxazolone-induced colitis by inhibiting the NF-κB pathway
    Lu, Yunmin
    Zhu, Meiying
    Chen, Wei
    Yin, Li
    Zhu, Jinshui
    Chen, Niwei
    Chen, Weixiong
    CLINICAL AND INVESTIGATIVE MEDICINE, 2014, 37 (01):
  • [25] Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy
    Genovese, M. C.
    Schiff, M.
    Luggen, M.
    Becker, J-C
    Aranda, R.
    Teng, J.
    Li, T.
    Schmidely, N.
    Le Bars, M.
    Dougados, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (04) : 547 - 554
  • [26] Oxazolone-induced colitis: An animal model of ulcerative colitis treatable with antibodies to IL-4.
    Fuss, IJ
    Boirivant, M
    Chu, AC
    Strober, W
    GASTROENTEROLOGY, 1998, 114 (04) : A980 - A981
  • [27] Intestinal vitamin D receptor knockout protects from oxazolone-induced colitis
    Shi, Yongyan
    Liu, Ziyun
    Cui, Xuewei
    Zhao, Qun
    Liu, Tianjing
    CELL DEATH & DISEASE, 2020, 11 (06)
  • [28] Grifola frondosa polysaccharide's therapeutic potential in oxazolone-induced ulcerative colitis
    Liu, Xiaoyi
    Zhang, Mingjun
    Chen, Shuai
    Liu, Huijuan
    Ma, Haoran
    Hu, Ting
    Luo, Peng
    Wei, Shaofeng
    CARBOHYDRATE POLYMERS, 2024, 344
  • [29] Intestinal vitamin D receptor knockout protects from oxazolone-induced colitis
    Yongyan Shi
    Ziyun Liu
    Xuewei Cui
    Qun Zhao
    Tianjing Liu
    Cell Death & Disease, 11
  • [30] Efficacy and safety of abatacept, a co-stimulation modulator, in children and adolescents with active juvenile idiopathic arthritis: Results of double-blind withdrawal phase
    Ruperto, N.
    Giannini, E. H.
    Prieur, A. M.
    Paz, E.
    Rubio-Perez, N. E.
    Silva, C. A.
    Abud, C.
    Burgos-Vargas, R.
    Gerloni, V.
    Melo-Gomes, J. A.
    Magalhes, C. Saad
    Sztajnbok, F.
    Goldenstein-Schainberg, C.
    Scheinberg, M.
    Hashkes, R.
    Horn, C.
    Sigal, L. H.
    Block, A. J.
    Covucci, A.
    Comet, P. L. N.
    Pagliaro, L.
    Martini, A.
    Lovell, D. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 87 - 87
12345